Pharmaceuticals

The Increase In Respiratory Infections Drives The Growth Of The Market Due To Rising Air Pollution And Vulnerability In Children Is Supporting Development Across The Pediatric Asthma Treatment Market

May 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Pediatric Asthma Treatment Market Change Between 2026 And 2030?

The pediatric asthma treatment market has seen substantial growth in recent years. It is anticipated to expand from $11.65 billion in 2025 to $12.31 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.7%. The growth observed in the past can be attributed to factors such as the restricted availability of asthma medications designed specifically for children, a reliance on hospital-based care, the increasing occurrence of childhood asthma, enhanced awareness among caregivers, and the continued use of conventional inhalers and short-acting beta agonists.

The pediatric asthma treatment market is projected to experience substantial expansion over the coming years. This market is anticipated to reach $15.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.3%. This projected growth is driven by factors such as the development of biologics and combination treatments, the incorporation of digital health monitoring solutions, the broadening of home care services, increasing uptake of online pharmacies, and a rise in regulatory clearances for pediatric asthma medications. Key trends during this period are expected to encompass a greater embrace of personalized pediatric asthma treatments, increased reliance on biologic therapies and combination inhalers, an increase in home care and remote patient monitoring, the expansion of online and retail pharmacy distribution networks, and an emphasis on early diagnosis and preventative asthma strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25868&type=smp

What Influential Factors Are Boosting The Pediatric Asthma Treatment Market Demand?

The escalating occurrence of respiratory infections is projected to drive the expansion of the pediatric asthma treatment market moving forward. Respiratory infections are defined as illnesses affecting the respiratory tract, including the nose, throat, airways, and lungs, caused by viruses, bacteria, or other pathogens. The increasing prevalence of these infections primarily stems from rising air pollution, as exposure to pollutants such as particulate matter and nitrogen dioxide compromises the respiratory system, making individuals more susceptible. Pediatric asthma treatment contributes to reducing the frequency and severity of respiratory infections by enhancing airway function and minimizing inflammation, thereby lowering vulnerability to infectious triggers. For instance, in June 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that in 2023, chronic obstructive pulmonary disease accounted for 3.6% of the total disease burden and 50% of the overall burden of respiratory conditions. Therefore, the growing prevalence of respiratory infections acts as a significant catalyst for the pediatric asthma treatment market’s growth.

Which Segment-Based Categories Are Covered In The Pediatric Asthma Treatment Market?

The pediatric asthma treatment market covered in this report is segmented –

1) By Type: Long-Term Control Medications, Quick-Relief Medications, Other Types

2) By Drug Class: Inhaled Corticosteroids, Long-Acting Beta Agonists, Leukotriene Modifiers, Antihistamines, Biologics

3) By Route Of Administration: Oral Route, Nasal Route, Injectable Route

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals, Clinics, Home Care, Other End users

Subsegments:

1) By Long-Term Control Medications: Inhaled Corticosteroids, Leukotriene Modifiers, Long-Acting Beta Agonists, Combination Inhalers, Biologic Therapies

2) By Quick-Relief Medications: Short-Acting Beta Agonists, Anticholinergics, Systemic Corticosteroids

3) By Other Types: Immunotherapy, Methylxanthines, Alternative Therapies

Which Trends Are Shaping The Pediatric Asthma Treatment Market Landscape?

Leading companies within the pediatric asthma treatment market are concentrating on creating innovative therapies, like monoclonal antibodies, to address and diminish airway inflammation in children. Monoclonal antibodies are proteins crafted in laboratories to replicate the immune system’s function of combating harmful pathogens by precisely targeting specific cells or substances. For example, in April 2024, AstraZeneca PLC, a pharmaceutical and biotechnology enterprise from the UK, secured approval from the U.S. Food and Drug Administration for FASENRA (benralizumab) as an additional maintenance therapy for children aged 6 to 11 years suffering from severe asthma linked to an eosinophilic phenotype. This antibody is formulated to decrease asthma exacerbations and enhance symptom management by targeting and eradicating eosinophils. Fasenra is administered as a subcutaneous injection once every 4 weeks for the initial three doses, then transitioning to once every 8 weeks, with pediatric dosing calibrated according to body weight.

Who Are The Firms Contributing To The Pediatric Asthma Treatment Market Ecosystem?

Major companies operating in the pediatric asthma treatment market are Pfizer Inc., Merck And Co Inc., Novartis AG, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Genentech Inc., Chiesi Farmaceutici S.p.A, Dr. Reddy’s Laboratories Ltd, Cipla Ltd, Lupin Limited, Zydus Lifesciences Ltd.

Access The Complete Pediatric Asthma Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/pediatric-asthma-treatment-global-market-report

Which Geographic Region Represents The Largest Pediatric Asthma Treatment Market Share?

North America was the largest region in the pediatric asthma treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric asthma treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Pediatric Asthma Treatment Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=25868&type=smp

Browse Through More Reports Similar to the Global Pediatric Asthma Treatment Market 2026, By The Business Research Company

Asthma Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Anti Asthmatics And Copd Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/anti-asthmatics-and-copd-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795